Search

Your search keyword '"Piga, M."' showing total 662 results

Search Constraints

Start Over You searched for: Author "Piga, M." Remove constraint Author: "Piga, M."
662 results on '"Piga, M."'

Search Results

1. Mood Disorder Questionnaire Positivity in Systemic Lupus Erythematosus and Other Chronic Diseases including Screen Bipolar Disorders or Rhythm and Energy Dysregulation Syndromes (DYMERS)

3. AB1041 IMPACT OF ANIFROLUMAB ON DISEASE BURDEN IN SYSTEMIC LUPUS ERYTHEMATOSUS: REAL-WORLD DATA FROM A MULTICENTRIC COHORT

4. AB1129 PATIENTS AND PHYSICIANS TREATMENT PREFERENCES FOR SYSTEMIC LUPUS ERYTHEMATOSUS: A COMPARATIVE ANALYSIS OF COMPLEMENTARY DISCRETE CHOICE EXPERIMENTS

5. AB1195 NINTEDANIB RESTORES ENDOTHELIAL FUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY FINDINGS OF A MONOCENTRIC STUDY

6. POS0747 DIFFERENCES AND SIMILARITIES IN CARDIOVASCULAR RISK ESTIMATION WITH FIVE DIFFERENT PREDICTION MODELS IN RHEUMATOID ARTHRITIS: DATA FROM THE CARDIOVASCULAR OBESITY AND RHEUMATIC DISEASE STUDY GROUP OF THE ITALIAN SOCIETY OF RHEUMATOLOGY

8. Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis

9. Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus

10. Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity

11. Relationship between the prevalence of subclinical tenosynovitis and treatment in patients with RA in clinical remission: STARTER study

12. Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet’s Syndrome

13. Musculoskeletal ultrasound may narrow the gap between patients and physicians in the assessment of rheumatoid arthritis disease activity

14. The AutoInflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

15. Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study

16. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies

17. Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review

18. Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care

19. OP0027 APPLICATION OF PREVENTIVE CV RISK STRATEGIES FOR DYSLIPIDEMIA IN RHEUMATOID ARTHRITIS PATIENTS: DATA FROM THE CARDIOVASCULAR OBESITY AND RHEUMATIC DISEASES (CORDIS) STUDY GROUP OF THE ITALIAN SOCIETY OF RHEUMATOLOGY

22. POS1172 GEOGRAPHICAL VARIABILITY OF ORGAN DAMAGE BURDEN IN A LARGE INTERNATIONAL MULTICENTER COHORT OF PATIENTS WITH BEHÇET’S SYNDROME: PRELIMINARY RESULTS OF THE PROBE STUDY

25. AB0558 ANIFROLUMAB IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS: A REAL-LIFE, MULTICENTER STUDY

26. A patient-driven registry on Behçet's disease: the AIDA for patients pilot project

27. Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry

28. La fatigue est indépendamment associée à l’activité de la maladie évaluée par le Physician Global Assessment (PGA) chez les patients atteints de lupus systémique

30. Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)

32. S14.1 The effect of anti-ribosomal-p and anti-dweys antibodies on depression and behavioral cognitive processes in systemic lupus erythematosus : an integrated clinical and functional MRI study

33. PO.6.133 Dynamical trajectory of glucocorticoid tapering and discontinuation in real-world patients with newly diagnosed systemic lupus erythematosus: the gulp study

34. Clinical potential of apremilast in the treatment of psoriatic arthritis

35. Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort

37. Development and implementation of the AIDA International Registry for patients with Behçet's disease

38. Development and implementation of the AIDA International Registry for patients with VEXAS syndrome

39. Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group

40. AB0636 Relationship between organ damage and impairment of health-related quality of life in patients with Behçet’s Syndrome: results from a longitudinal extension of the BODI Project.

41. POS0787 THE EFFECT OF ANTI-RIBOSOMAL-P AND ANTI-NR2 ANTIBODIES ON FUNCTIONAL BRAIN MRI NETWORKS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH DEPRESSION AND BEHAVIORAL COGNITIVE DISORDERS.

42. AB0630 Assessment of organ damage accrual in Behçet's Syndrome over 2-year follow-up: results from the BODI Project longitudinal extension.

43. AB0631 Impact of Behçet’s Syndrome on work activity and productivity: results from a sub-analysis of the BODI Project cohort.

45. 'Capitolo 5. Istituzioni'

46. Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

47. Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9)

49. Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome)

Catalog

Books, media, physical & digital resources